| Revision as of 12:48, 12 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/Drugbox← Previous edit |
Latest revision as of 12:23, 13 May 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers172,859 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper |
| (16 intermediate revisions by 14 users not shown) |
| Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{drugbox |
|
|
|
{{Missing information|indication, producer, ...|date=November 2017}} |
|
|
{{Drugbox |
|
⚫ |
| verifiedrevid = 444433060 |
|
⚫ |
| IUPAC_name = |
|
⚫ |
| image = |
|
|
<!-- Clinical data --> |
|
|
| tradename = |
|
|
| Drugs.com = {{drugs.com|international|molgramostim}} |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
⚫ |
| pregnancy_category = |
|
⚫ |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
⚫ |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = |
|
|
<!-- Pharmacokinetic data --> |
|
⚫ |
| bioavailability = |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
<!-- Identifiers --> |
|
|
| CAS_number_Ref = {{cascite|correct|CAS}} |
|
⚫ |
| CAS_number = 99283-10-0 |
|
⚫ |
| ATC_prefix = L03 |
|
⚫ |
| ATC_suffix = AA03 |
|
⚫ |
| PubChem = |
|
⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
⚫ |
| DrugBank = |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = B321AL142J |
|
| UNII = B321AL142J |
|
|
| ChemSpiderID = none |
| ⚫ |
| verifiedrevid = 443729228 |
|
|
|
<!-- Chemical data --> |
| ⚫ |
| IUPAC_name = |
|
|
⚫ |
| chemical_formula = |
| ⚫ |
| image = |
|
|
⚫ |
| molecular_weight = |
| ⚫ |
| CAS_number = |
|
| ⚫ |
| ATC_prefix = L03 |
|
| ⚫ |
| ATC_suffix = AA03 |
|
| ⚫ |
| PubChem = |
|
| ⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| ⚫ |
| DrugBank = |
|
| ⚫ |
| chemical_formula = |
|
| ⚫ |
| molecular_weight = |
|
| ⚫ |
| bioavailability = |
|
| ⚫ |
| protein_bound = |
|
| ⚫ |
| metabolism = |
|
| ⚫ |
| elimination_half-life = |
|
| ⚫ |
| excretion = |
|
| ⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| ⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
| ⚫ |
| pregnancy_category= |
|
| ⚫ |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| ⚫ |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| ⚫ |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| ⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| ⚫ |
| legal_status = |
|
| ⚫ |
| routes_of_administration = |
|
|
}} |
|
}} |
|
'''Molgramostim''' is a ] ] which functions as a ].<ref name="pmid16883311">{{cite journal |author=Quittet P, Ceballos P, Lopez E, ''et al.'' |title=Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients |journal=Bone Marrow Transplant. |volume=38 |issue=4 |pages=275–84 |year=2006 |pmid=16883311 |doi=10.1038/sj.bmt.1705441 |pmc=2100150}}</ref><ref name="pmid16490891">{{cite journal |author=Orozco H, Arch J, Medina-Franco H, ''et al.'' |title=Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial |journal=Archives of surgery (Chicago, Ill. : 1960) |volume=141 |issue=2 |pages=150–3; discussion 154 |year=2006 |pmid=16490891 |doi=10.1001/archsurg.141.2.150}}</ref> |
|
'''Molgramostim''' is a ] ] which functions as an ].<ref name="pmid16883311">{{cite journal |vauthors=Quittet P, Ceballos P, Lopez E, etal |title=Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients |journal=Bone Marrow Transplant. |volume=38 |issue=4 |pages=275–84 |year=2006 |pmid=16883311 |doi=10.1038/sj.bmt.1705441 |pmc=2100150|url=http://www.hal.inserm.fr/inserm-00136076/document }}</ref><ref name="pmid16490891">{{cite journal |vauthors=Orozco H, Arch J, Medina-Franco H, etal |title=Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial |journal=Archives of Surgery |volume=141 |issue=2 |pages=150–3; discussion 154 |year=2006 |pmid=16490891 |doi=10.1001/archsurg.141.2.150|doi-access=free }}</ref> |
|
|
|
|
|
==References== |
|
==References== |
|
{{reflist}} |
|
{{Reflist|2}} |
|
|
|
|
|
{{Immunostimulants}} |
|
{{Immunostimulants}} |
|
|
{{Cytokine receptor modulators}} |
|
|
{{Growth factor receptor modulators}} |
|
|
|
|
|
] |
|
] |
| Line 39: |
Line 51: |
|
|
|
|
|
{{antineoplastic-drug-stub}} |
|
{{antineoplastic-drug-stub}} |
|
|
|
|
] |
|